Newborn Screening for Sickle Cell Disease in Ghana Update

Size: px
Start display at page:

Download "Newborn Screening for Sickle Cell Disease in Ghana Update"

Transcription

1 National Programme of Newborn Screening for Sickle Cell Disease Newborn Screening for Sickle Cell Disease in Ghana Update Prof. Kwaku Ohene-Frempong, MD Children s Hospital of Philadelphia University of Pennsylvania Sickle Cell Foundation of Ghana Sickle Cell Foundation of Ghana

2 Newborn Screening for SCD Why screen newborns for sickle cell disease? Sickle Cell Foundation of Ghana

3 Newborn Screening for SCD Causes of Death in SCD-SS (0-10 yr) Overall incidence: 1.1/100 person-yrs (Gill FM, et al, CSSCD: 1995) Sickle Cell Foundation of Ghana

4 Newborn Screening for SCD Bacteremia in SCD-SS Disease, CSSCD Age (yr) < >20 No. pts Person-yr No. events Incidence/ 7,979 2,536 1, Pr-yr Deaths (Zarkowsky,et al. CSSCD; J Pediatr 1986: ) Sickle Cell Foundation of Ghana

5 Newborn Screening for SCD Incidence of Strep. pneumoniae in SCD-SS Disease, CSSCD Age (yr) <1* No. pts Pt.yrs No. events Incidence 6,382 6,343 4, ,445 1, Pr-yr US (98-99)^ * 3 patients were younger than 6 months of age ^ MMWR, 2008 :57; 144 (Zarkowsky,et al. CSSCD; J Pediatr 1986: ) Sickle Cell Foundation of Ghana

6 Newborn Screening for SCD Sickle Cell Foundation of Ghana

7 Newborn Screening for SCD Penicillin Prophylaxis Study (I), CSSCD Penicillin Placebo No.of patients (Person-yr ) Age 3-36m Pneumovax 67% 71.6% Pneumococcal sepsis 2 13 (Incidence/10 5 Pr-yr 1,524 9,455) Deaths 0 3 (Youngest septic patient: 6 mo. old) (Gaston, et al. CSSCD; NEJM 1986: ) Sickle Cell Foundation of Ghana

8 Newborn Screening for SCD Sickle Cell Foundation of Ghana

9 Pneumococcal Disease in Africa Interpretation Introduction of conjugate vaccines against S pneumoniae and H influenzae into the childhood immunisation schedules of African countries could substantially affect survival of children with sickle-cell anaemia Williams, et al., Lancet Oct 17;374(9698):

10 Newborn Screening for SCD Infection in Sickle Cell Disease Malaria and Bacteremia Risks in SCD Kenya 7164 hospitalized children, < 5y, living on the coast of Kenya Age-adjusted odds ratios for disease-specific admission by Hb S genotype Case category Hb AA Hb AS p* SCA p* Uncomplicated malaria 1 Severe malaria 1 Non-malaria illnesses 1 Bacteremia 1 S. pneumoniae ( ) 0.12 ( ) 0.78 ( ) 0.60 ( ) <0.001 < < ( ) 0.80 ( ) 4.17 ( ) 8.73 ( ) 15.3 ( ) <0.001 <0.001 <0.001 Values are ORs (95% CI) compared with the reference group (HbAA) adjusted for age group (0-23 months, months) by logistic regression. McAuley, et al., Blood Sep 9;116(10):

11 Newborn Screening for Sickle Cell Disease in Ghana Kumasi-Tikrom Pilot Project Sickle Cell Foundation of Ghana

12 Newborn Screening for SCD in Ghana Kumasi-Tikrom Pilot Project Project Funding 1. U.S. Government: National Heart, Lung, and Blood Institute (NHLBI) of National Institutes of Health (NIH), Comprehensive Sickle Cell Center Grant: ; ; Government of Ghana Ministry of Health and Ghana Health Service - Staff 3. Children s Hospital of Philadelphia (CHOP) - Staff and donations 4. General public - donations Sickle Cell Foundation of Ghana

13 Newborn Screening for SCD in Ghana Results: Feb 15, 1995 Dec 31, 2011 Hb Phenotype Number Percentage F FA FAC FAS FC FS FSA FSC OTHER TOTAL 343, Babies with SCD totaled 6,025 (1.75%)

14 Newborn Screening for SCD in Ghana Tracking Results: Feb 15, 1995 Dec 31, 2011 Total screened with results 343,355 Babies with Possible SCD 6, Total accounted for 5, Lost to follow-up Total contacted 4, (19% reported, 81% tracked) Dead by contact date Eligible for enrollment 4,810 No. (%) Still under active tracking Known dead after enrollment 4.5

15 KUMASI CENTER FOR SICKLE CELL DISEASE Clinic Population SCD Clinic started on 14 th December, 1992 with 10 adult patients Total Number of registered patients in Clinic by 30 th September, 2011: Newborn screened: 4,028 Non-newborns: 8,168 GRAND TOTAL 12,196

16 Kumasi Centre for Sickle Cell Disease Appointments-Routine Clinic Visits Frequency of well-child visits: Less than 2 yrs: Every 2 mo More than 2 yrs: Every 3 mo Adolescents and adults: every 4-6 mo Patients may be seen more frequently depending on clinical status

17 Kumasi Centre for Sickle Cell Disease Antimicrobial Prophylaxis Penicillin prophylaxis: o o o Recommended for the first five years but may be optional after 5 years 125 mg twice daily (< 3 yr old); 250 mg twice daily (> 3 yr old). o Erythromycin ethyl succinate (EES) 10 mg/kg/dose, twice daily for those allergic to penicillin Anti-malaria Chemoprophylaxis:?? Unclear recommendation: NMCP POLICY for high

18 Newborn Screening for SCD in Ghana Kumasi-Tikrom Pilot Project Conclusions 1. Newborn screening for SCD makes sense in Africa. 2. Implementation of a Public Health Newborn Screening Programme is feasible in Ghana in both rural and urban settings. 3. Ghanaian healthcare systems and staff can support all phases of comprehensive management of SCD. 4. Children with SCD born in Ghana, diagnosed at birth and given comprehensive healthcare, have reduced mortality. Sickle Cell Foundation of Ghana

19 Newborn Screening for SCD in Ghana Progress Report (1/2) 1. US funding for pilot project ended March Screening has continued with support from MOH, GHS, Children s Hospital of Philadelphia, and Sickle Cell Foundation of Ghana (SCFG) 3. SCFG proposal for national scale-up submitted to Ministry of Health 2006 and : Planning meetings among MOH, Ghana Health Service, SCFG, National Health Insurance Authority 5. SCFG secures support from Brazil Government Sickle Cell Foundation of Ghana

20 Newborn Screening for SCD in Ghana Progress Report (2/2) 6. Brazil-Ghana Technical Cooperation Agreement in SCD signed (Sep 2009) 7. National Programme of Newborn Screening for SCD launched Nov 2010 Technical Advisory Committee inaugurated Screening Plan submitted to MOH, Nov 2011 Steering Committee being established 8. National scale-up in ALL other Regions, Initial Regional Training Workshops completed Nov, Sickle Cell Foundation of Ghana

21 Ghana: National Newborn Screening Program Technical Advisory Committee DRAFT POLICY FOR NEWBORN SCREENING IN GHANA AND TECHNICAL PLAN FOR NATIONAL SCALE UP OF NEWBORN SCREENING FOR SICKLE CELL DISEASE November 1, 2011

22 Newborn Screening for SCD in Ghana Population: Birth Rate: 25.2 million No. of Births: 680,148 SCD Rate: No. SCD babies 12,243 SCD Births in Ghana (2012 Estimates) / 1,000 population 1.8% (pilot newborn screening data) Sickle Cell Foundation of Ghana

23 Ghana: National SCD Programme Organization of Centres for Sickle Cell Disease National Coordinating Centre Regional Centre for SCD Sub-Regional Centres for SCD Sickle Cell Foundation of Ghana

24 Ghana: National Newborn Screening Program Initial Education and Training Program Training Program 1: Training Program 2: Training Program 3: Training Program 4: Public Health Workers Clinical Staff of Centers Sample Collectors Data Entry Staff Counselor Training and Certification Program

25 Ghana: National Newborn Screening Program Training Program 1 Regional Workshops on Newborn Screening for Sickle Cell Disease

26 Ghana: National Newborn Screening Program Training Program 1:Regional Workshops H H H H H H H

27 Ghana: National Newborn Screening Program NNbSP-SCD Training Program 1 (2011) Trainees by Profession Community Health Nurses 60 (10.9) General Nurses 80 (14.5) Public Health Nurses 85 (15.4) Midwives Doctors Physician Assists. 127 (23.0) 111 (20.0) 54 (9.8) Others 34 (6.4) TOTAL 551 (100)

28 Ghana: National Newborn Screening Program NNbSP-SCD Training Program 1 (2011): Trainees % Total # % % % Other REGIONS Prescriber Professionals Midwives Nurses Professions s (%) Ashanti (9.8) Brong Ahafo (11.1) Central (12.9) Eastern (14.5) Great. Accra (14.9) Northern (8.5) Upper East (4.4) Upper West (2.0) Volta (10.9) Western (12.2) ALL Regions 125 (22.7) 247 (44.8) 174 (31.6) 5 (0.9) 551 (100)

29 Workshop on Newborn Screening for Sickle Cell Disease Pre- and Post-Test Test No. of Participants Average % Correct Median % Correct Pre-Test Post-Test Sickle Cell Foundation of Ghana

30 Newborn Screening Workshop Pre- and Post-test Question 3 List the four most common types of SCD Test % Correct Pre-Test 1 Post-Test 84 Sickle Cell Foundation of Ghana

31 Newborn Screening Workshop Pre- and Post-test Young children with severe SCD lose function of their spleen after 5 years of age Test Question 17 True / False % Correct Pre-Test 44 Post-Test 35 Sickle Cell Foundation of Ghana

32 Newborn Screening Workshop Pre- and Post-test Question 24 What is the most important treatment after newborns are diagnosed with SCD? Test % Correct Pre-Test 8 Post-Test 90 Sickle Cell Foundation of Ghana

33 National Newborn Screening Program Training Program 1: Regional Workshop Takoradi, Western Region, Nov 11-12, 2011

34 National Newborn Screening Program Training Program 1: Regional Workshop Koforidua, Eastern Region, Nov 17-18, 2011

35 International Partnership in SCD: Ghana Brazil-Ghana Partnership 1. October 2008: Application is submitted by Sickle Cell Foundation of Ghana to Brazilian Ambassador to Ghana 2. February 2009: Prof. Ohene-Frempong meets with President Mills; and, President Mills meets with Brazilian Ambassador 3. July 2009: 1 st Complementary Agreement is signed in Accra (Complementary to original 1974 Brazil-Ghana Technical Cooperation Agreement) 4. August-October 2009: Training in Brazil (Lab Techs and Nurses) 5. October 2009: Year 1 Technical Agreement is signed in Brazil 6. February 2011: 2 nd Complementary Agreement is signed in Accra Sickle Cell Foundation of Ghana

36 International Partnership in SCD: Ghana Brazil-Ghana Partnership Program Areas 1. Expansion of Screening Laboratory Capacity 2. Training of Lab Technologists, Nurses 3. Development of Educational Materials and Educational Program 4. Expansion of IT system and network 5. Construction of Blood and Sickle Cell Center in Kumasi Sickle Cell Foundation of Ghana

37 Thank you!

38 Brazil-Ghana Technical Cooperation in SCD Training of Technicians in Brazil, August 2009

39 Brazil-Ghana Technical Cooperation in SCD2 nd Brazilian Delegation Meets President Mills, Dec 09

40 Brazil-Ghana Technical Cooperation in SCD Asantehene Fetes 2 nd Brazilian Delegation, Dec 09

41 Brazil-Ghana Technical Cooperation in SCD Asantehene Fetes 2 nd Brazilian Delegation, Dec 09

42 Brazil-Ghana Blood and Sickle Cell Center Computer Model

43 Brazil-Ghana Blood and Sickle Cell Center Computer Model

44 Brazil-Ghana Technical Cooperation in SCD Brazil-Ghana Blood and Sickle Cell Center Survey of Plot at KATH

45 Brazil-Ghana Technical Cooperation in SCD Kumasi Blood and Sickle Cell Center Groundbreaking, Nov 25, 2010

Newborn Screening for Sickle Cell Disease in Africa: Public health meets reality

Newborn Screening for Sickle Cell Disease in Africa: Public health meets reality 13 th September 2016 Newborn Screening for Sickle Cell Disease in Africa: Public health meets reality Kwaku Ohene-Frempong. MD Children s Hospital of Philadelphia Sickle Cell Foundation of Ghana Disclosure

More information

Kenya Sickle Cell Care

Kenya Sickle Cell Care Kenya Sickle Cell Care Title name: Outreach Programs and Advocacy of Sickle Cell Disease Care in Kenya Presenter: Samuel Misiani Mbunya Administrator: AMPATH Hematology Made possible by the generous support

More information

Sickle Cell Service to Humanity Foundation, Katsina State, Nigeria: Exploratory Visit

Sickle Cell Service to Humanity Foundation, Katsina State, Nigeria: Exploratory Visit Sickle Cell Service to Humanity Foundation, Katsina State, Nigeria: Exploratory Visit Nigerian Sickle Cell Cohort Team, UNDP N-253 project contact (+2348036063948) Dr Baba Inusa (Chief Investigator) Dr

More information

Expanding Newborn Screening Programs Globally: Current Initiatives and Future Directions

Expanding Newborn Screening Programs Globally: Current Initiatives and Future Directions Expanding Newborn Screening Programs Globally: Current Initiatives and Future Directions Fizza Gulamali-Majid, PhD Maryland Department of Health and Mental Health APHL Vision A healthier world through

More information

Women by area: Urban F Women by area: Rural F

Women by area: Urban F Women by area: Rural F Vitamin and Mineral Nutrition Information System (VMNIS) WHO Global Database on Vitamin A Deficiency The Vitamin A Deficiency database includes data by country based on xerophthalmia and/or serum or plasma

More information

Antiretroviral Pharmacovigilance Training Course. Dar es Salaam, United Republic of Tanzania

Antiretroviral Pharmacovigilance Training Course. Dar es Salaam, United Republic of Tanzania Antiretroviral Pharmacovigilance Training Course Dar es Salaam, United Republic of Tanzania 23 rd 28 th November 2009 SAFETY MONITORING OF ARVs IN GHANA NATIONAL AIDS/STI CONTROL PROGRAMME FOOD AND DRUGS

More information

Vaccination Programs: Client-Held Paper Immunization Records

Vaccination Programs: Client-Held Paper Immunization Records Vaccination Programs: Client-Held Paper Immunization Records Summary Evidence Table Updated Evidence (search period: 1980-February 2012) population, Setting, Dickey (1992) Period: 1988-1989 Greatest (Group

More information

The relationship between adherence to clinic appointments and year-one mortality for HIV infected patients at a Referral Hospital in Western Kenya

The relationship between adherence to clinic appointments and year-one mortality for HIV infected patients at a Referral Hospital in Western Kenya The relationship between adherence to clinic appointments and year-one mortality for HIV infected patients at a Referral Hospital in Western Kenya Muthusi, K; Burmen, B 8th International Workshop on HIV

More information

Issue 9: January March, 2017 National Malaria Control Programme (NMCP) Box KB 493 Korle - Bu Accra Ghana

Issue 9: January March, 2017 National Malaria Control Programme (NMCP) Box KB 493 Korle - Bu Accra Ghana Issue 9: January March, 2017 National Malaria Control Programme (NMCP) Box KB 493 Korle - Bu Accra Ghana Contents Page Editorial and Report Highlights 1 Malaria Burden 2 Key activities undertaken in First

More information

HIV and AIDS in Ghana. Epidemic update National AIDS/STI Control Programme Ghana Health Service

HIV and AIDS in Ghana. Epidemic update National AIDS/STI Control Programme Ghana Health Service HIV and AIDS in Ghana Epidemic update National AIDS/STI Control Programme Ghana Health Service CPS Medical Knowledge Fiesta August 8/9/ NACP@ CPS Knowledge Fiesta 1 Outline Epidemiology of HIV The Global

More information

Issue 8: January December 2016 National Malaria Control Programme (NMCP) Box KB 493 Korle - Bu Accra Ghana

Issue 8: January December 2016 National Malaria Control Programme (NMCP) Box KB 493 Korle - Bu Accra Ghana Issue 8: January December National Malaria Control Programme (NMCP) Box KB 493 Korle - Bu Accra Ghana Contents Page Editorial and Report Highlights 1 Malaria Burden 2 Key Activities Undertaken in 2 Malaria

More information

Overview of the Malaria Vaccine Implementation Programme (MVIP) Prof. Fred Were SAGE meeting 17 April, 2018

Overview of the Malaria Vaccine Implementation Programme (MVIP) Prof. Fred Were SAGE meeting 17 April, 2018 Overview of the Malaria Vaccine Implementation Programme (MVIP) Prof. Fred Were SAGE meeting 17 April, 2018 1 Objectives Brief review Background EMA positive opinion and WHO recommendations Funding Description

More information

Macquarie University ResearchOnline

Macquarie University ResearchOnline Macquarie University ResearchOnline This is the author version of an article published as: Parr, N.J. (1998) 'Changes in the Factors Affecting Fertility in Ghana During the Early Stages of the Fertility

More information

If these vaccines haven t been given, please follow guidelines below for emergency procedures.

If these vaccines haven t been given, please follow guidelines below for emergency procedures. MANAGEMENT OF PATIIENTS POST SPLENECTOMY & HYPOSPLENIIC PATIIENTS Splenectomised and hyposplenic patients are at increased risk of life-threatening infections due to encapsulated micro-organisms such as

More information

Shabir A. Madhi. Progress and Challenges of Immunization Contributing Toward Attaining the MDG Goal to Reduce under-5 Childhood Mortality.

Shabir A. Madhi. Progress and Challenges of Immunization Contributing Toward Attaining the MDG Goal to Reduce under-5 Childhood Mortality. Shabir A. Madhi Progress and Challenges of Immunization Contributing Toward Attaining the MDG Goal to Reduce under-5 Childhood Mortality. National Institute for Communicable Diseases & University of Witwatersrand,

More information

Issue 6: January - June 2016 National Malaria Control Programme (NMCP) Box KB 493 Korle - Bu Accra Ghana

Issue 6: January - June 2016 National Malaria Control Programme (NMCP) Box KB 493 Korle - Bu Accra Ghana Issue 6: January - June 2016 National Malaria Control Programme (NMCP) Box KB 493 Korle - Bu Accra Ghana Contents Page Editorial and Report Highlights Page 1 Malaria Burden Page 2 Key Activities undertaken

More information

MALARIA CONTROL as a best practice Corporate Social Responsibility Programme

MALARIA CONTROL as a best practice Corporate Social Responsibility Programme GHANA MALARIA CONTROL as a best practice Corporate Social Responsibility Programme Steve Knowles Programme Director Steve Knowles (AngloGold Ashanti Malaria Programme Director) says: A Malaria Control

More information

HAEMOPHILUS INFLUENZAE INVASIVE DISEASE

HAEMOPHILUS INFLUENZAE INVASIVE DISEASE 23 Annual Morbidity Report HAEMOPHILUS INFLUENZAE INVASIVE DISEASE CRUDE DATA 35 Annual Incidence a LA County.37 California b. United States c.2 Age at Diagnosis Mean 4. years Median 36. years Range Birth

More information

Bridging the Gap: Improving Sickle Cell Disease Transition from Pediatric- to Adult-Focused Care ASFA 2017 Annual Meeting

Bridging the Gap: Improving Sickle Cell Disease Transition from Pediatric- to Adult-Focused Care ASFA 2017 Annual Meeting Bridging the Gap: Improving Sickle Cell Disease Transition from Pediatric- to Adult-Focused Care ASFA 2017 Annual Meeting Kim Smith-Whitley, MD Director Comprehensive Sickle Cell Center The Children s

More information

The Power of Partnership

The Power of Partnership The Power of Partnership Helen Scott, PhD Executive Director, CanWaCH Best Start Resource Centre Annual Conference February 8, 2018 - Toronto CanWaCH.ca CanSFE.ca The Concept: We can do more and we can

More information

Early Infant Diagnosis-Malawi Experience. P.N.Kazembe

Early Infant Diagnosis-Malawi Experience. P.N.Kazembe Early Infant Diagnosis-Malawi Experience P.N.Kazembe MALAWI HIV/AIDS DATA Total population 12.8 million HIV prevalence 14% (15-49 yrs) Antenatal HIV prevalence 15%. 81,000 HIV infected women deliver/yr

More information

Launch of a supplement in Health Policy and Planning. Dr. Joy Lawn Mary Kinney Anne Pfitzer On behalf of the team

Launch of a supplement in Health Policy and Planning. Dr. Joy Lawn Mary Kinney Anne Pfitzer On behalf of the team A Decade of Change for Newborn Survival Launch of a supplement in Health Policy and Planning Dr. Joy Lawn Mary Kinney Anne Pfitzer On behalf of the team Overview of the supplement Editorial Gary Darmstadt,

More information

Malaria Vaccine Implementation Programme (MVIP) update and framework for policy decision. Mary J Hamel, WHO MPAC, 11 April 2018

Malaria Vaccine Implementation Programme (MVIP) update and framework for policy decision. Mary J Hamel, WHO MPAC, 11 April 2018 Malaria Vaccine Implementation Programme (MVIP) update and framework for policy decision Mary J Hamel, WHO MPAC, 11 April 2018 MVIP update Background to MVIP MVIP Updates Regulatory Vaccine introduction

More information

Green Amber Red Assurance Level

Green Amber Red Assurance Level A re-audit of the turnaround time of samples for the Sickle Cell and Thalassaemia Newborn Screening Programme, in the Manchester Newborn Screening Laboratory Clinical Audit Report May 2014 Clinical Audit

More information

Potential public health impact of RSV vaccines. R. Karron December 2016

Potential public health impact of RSV vaccines. R. Karron December 2016 Potential public health impact of RSV vaccines R. Karron December 2016 1. RSV is The leading cause of hospitalization in infants and in many high-income countries; >2 million medical visits annually in

More information

National Institute for Communicable Diseases -- Weekly Surveillance Report --

National Institute for Communicable Diseases -- Weekly Surveillance Report -- Weekly Surveillance Report Week 43, 216 National Institute for Communicable Diseases -- Weekly Surveillance Report -- Page 2 Laboratory-Based Respiratory & Meningeal Disease Surveillance 3 Neisseria meningitidis

More information

GSK Medicine: Study No.: Title: Rationale: Study Period Objectives: Indication: Study Investigators/Centers: Research Methods: Data Source:

GSK Medicine: Study No.: Title: Rationale: Study Period Objectives: Indication: Study Investigators/Centers: Research Methods: Data Source: The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.

More information

Balance Sheets 1. CHILD HEALTH... PAGE NUTRITION... PAGE WOMEN S HEALTH... PAGE WATER AND ENVIRONMENTAL SANITATION...

Balance Sheets 1. CHILD HEALTH... PAGE NUTRITION... PAGE WOMEN S HEALTH... PAGE WATER AND ENVIRONMENTAL SANITATION... Balance Sheets A summary of the goals, gains and unfinished business of the 1990-2000 decade as included in the Report of the Secretary-General, 'We the Children: End-decade review of the follow-up to

More information

Building and Enhancing Laboratory Capacity for Screening and Diagnosis of Hemoglobinopathies. Presented by M.Christine Dorley -TNDOH

Building and Enhancing Laboratory Capacity for Screening and Diagnosis of Hemoglobinopathies. Presented by M.Christine Dorley -TNDOH Building and Enhancing Laboratory Capacity for Screening and Diagnosis of Hemoglobinopathies Presented by M.Christine Dorley -TNDOH Reasons Millions are affected globally i.e. Sickle Cell Disease 1/500

More information

Background. Proposed to develop a framework for action. Address by Foreign Minister Koumura

Background. Proposed to develop a framework for action. Address by Foreign Minister Koumura July 2008 Ministry of Foreign Affairs of Japan Background Address by Foreign Minister Koumura Global Health and Japan s Foreign Policy From Okinawa to Toyako (25 November 2007) Special Address by Prime

More information

Vaccination Programs: Provider Assessment and Feedback

Vaccination Programs: Provider Assessment and Feedback Vaccination Programs: Provider Assessment and Feedback Summary Evidence Table Updated Evidence (search period: 1997-2012) Population and Bordley (2001), Margolis (2001) 1994-1997 Children up-to-date on

More information

H1N1 Influenza Vaccination in Massachusetts. April 15, 2010 Massachusetts Department of Public Health

H1N1 Influenza Vaccination in Massachusetts. April 15, 2010 Massachusetts Department of Public Health H1N1 Influenza Vaccination in Massachusetts April 15, 2010 Massachusetts Department of Public Health Initial Target Groups For H1N1 Vaccine Pregnant women HH contacts/caregivers of infants < 6 m/o HCP

More information

IPT BOTSWANA EXPERIENCE

IPT BOTSWANA EXPERIENCE IPT BOTSWANA EXPERIENCE Oaitse I Motsamai RN, MW, B Ed, MPH Ministry of Health Botswana 11 th November 2008 Addis Ababa, Ethiopia OUTLINE Botswana context Rationale for IPT in Botswana Pilot Current Programme

More information

Republic of Malawi SPEECH BY THE GUEST OF HONOUR, MINISTER OF HEALTH, HONOURABLE DR PETER KUMPALUME, MP AT THE OFFICAL OPENING OF

Republic of Malawi SPEECH BY THE GUEST OF HONOUR, MINISTER OF HEALTH, HONOURABLE DR PETER KUMPALUME, MP AT THE OFFICAL OPENING OF Republic of Malawi SPEECH BY THE GUEST OF HONOUR, MINISTER OF HEALTH, HONOURABLE DR PETER KUMPALUME, MP AT THE OFFICAL OPENING OF A PARTNERSHIP FOR MATERNAL NEWBORN & CHILD HEALTH MEETING UMODZI PARK BICC

More information

Kenya s experience in Influenza Vaccination Policy Development

Kenya s experience in Influenza Vaccination Policy Development Kenya s experience in Influenza Vaccination Policy Development Gideon Emukule Antananarivo, Madagascar, March 20th, 2018 3/28/2018 1 Influenza Vaccination Policy CoAg In Sep 2013, the Kenya MoH and CDC

More information

Safe Generations Harnessing Implementation Science to Assess the Impact of Option B+ in Swaziland

Safe Generations Harnessing Implementation Science to Assess the Impact of Option B+ in Swaziland Safe Generations Harnessing Implementation Science to Assess the Impact of Option B+ in Swaziland Background and Rationale In 2015, the World Health Organization (WHO) endorsed universal treatment for

More information

Update on Meningococcal A Vaccine Development and Introduction

Update on Meningococcal A Vaccine Development and Introduction Update on Meningococcal A Vaccine Development and Introduction WHO Product Development for Vaccines Advisory Committee Meeting (PD-VAC) @ Geneva, 7-9 September 2015 Dr Marie-Pierre Preziosi, WHO Initiative

More information

The World Bank Ghana - Maternal, Child Health and Nutrition Project (P145792)

The World Bank Ghana - Maternal, Child Health and Nutrition Project (P145792) Public Disclosure Authorized AFRICA Ghana Health, Nutrition & Population Global Practice IBRD/IDA Investment Project Financing FY 2014 Seq No: 7 ARCHIVED on 25-Sep-2017 ISR29449 Implementing Agencies:

More information

Recommended Childhood Immunization Schedu...ates, January - December 2000, NP Central

Recommended Childhood Immunization Schedu...ates, January - December 2000, NP Central Recommended Childhood Immunization Schedule United States, January - December 2000 Vaccines 1 are listed under routinely recommended ages. Solid-colored bars indicate range of recommended ages for immunization.

More information

Global landscape analysis and literature review of 2 nd Year of Life immunization platform

Global landscape analysis and literature review of 2 nd Year of Life immunization platform Global landscape analysis and literature review of 2 nd Year of Life immunization platform Global Vaccine and Immunization Research Forum 15-17 March 2016 Johannesburg, South Africa Imran Mirza; Celina

More information

Sickle Cell Disease Integrated Care Models: Outpatient and Inpatient National Minority Quality Forum April 2017

Sickle Cell Disease Integrated Care Models: Outpatient and Inpatient National Minority Quality Forum April 2017 Sickle Cell Disease Integrated Care Models: Outpatient and Inpatient National Minority Quality Forum April 2017 Kim Smith-Whitley, MD Director Comprehensive Sickle Cell Center The Children s Hospital of

More information

FAQs about Changes to DHR Immunization Rules and Regulations

FAQs about Changes to DHR Immunization Rules and Regulations FAQs about Changes to DHR Immunization Rules and Regulations 1. What are the new immunization rules changes? The new immunization rules changes include 1 new definition and changes in 4 vaccine requirements.

More information

Vaccine-Preventable Diseases in Colorado s Children 2009 Sean O Leary MD, Carl Armon PhD, Joni Reynolds, RNC, MSN, James Todd MD

Vaccine-Preventable Diseases in Colorado s Children 2009 Sean O Leary MD, Carl Armon PhD, Joni Reynolds, RNC, MSN, James Todd MD State of the Health of Colorado s Children Vaccine-Preventable Diseases in Colorado s Children 29 Sean O Leary MD, Carl Armon PhD, Joni Reynolds, RNC, MSN, James Todd MD Vaccines have been highly effective

More information

FAQs about Changes to DHR Immunization Rules and Regulations

FAQs about Changes to DHR Immunization Rules and Regulations FAQs about Changes to DHR Immunization Rules and Regulations 1. What are the new immunization rules changes? The new immunization rules changes include 1 new definition and changes in 4 vaccine requirements.

More information

We ll be our own lifesavers. We ll get the flu vaccine.

We ll be our own lifesavers. We ll get the flu vaccine. We ll be our own lifesavers. We ll get the flu vaccine. The flu vaccine is a lifesaver for older people and those with long-term health conditions. www.immunisation.ie Flu Vaccine 2017-18 What is seasonal

More information

Child Health Services

Child Health Services Chapter 4 Child Health Services 4.1 Background 4.1.1 Collection of Child Health Information According to the World Health Organization (WHO), many sick children who are brought to the attention of health

More information

THE SITUATION OF YELLOW FEVER IN THE AFRICAN REGION: THE PLAN TO END YF EPIDEMICS IN 2026

THE SITUATION OF YELLOW FEVER IN THE AFRICAN REGION: THE PLAN TO END YF EPIDEMICS IN 2026 THE SITUATION OF YELLOW FEVER IN THE AFRICAN REGION: THE PLAN TO END YF EPIDEMICS IN 2026 Dr Zabulon Yoti WHO AFRO Technical Coordinator for Health Emergencies 1 About 100 acute public health events annually

More information

Impact and effectiveness of national immunisation programmes. David Green, Nurse Consultant, Immunisations Public Health England

Impact and effectiveness of national immunisation programmes. David Green, Nurse Consultant, Immunisations Public Health England Impact and effectiveness of national immunisation programmes David Green, Nurse Consultant, Immunisations Public Health England Session objectives Immunisation planning and implementation The impact and

More information

World Toilet Day: Eradicating open defecation still a challenge in Ghana

World Toilet Day: Eradicating open defecation still a challenge in Ghana Dispatch No. 60 19 November 2015 World Toilet Day: Eradicating open defecation still a challenge in Ghana Afrobarometer Dispatch No. 60 Daniel Armah-Attoh Summary Ghana has been observing Toilet Day since

More information

Country Health System Fact Sheet 2006 Angola

Country Health System Fact Sheet 2006 Angola Population Total fertility rate (per woman) Adolescent fertility proportion Adult literacy rate Net primary school enrolment ratio Gross national income per capita Population living below the poverty line

More information

Obiageli E. Nnodu Associate Professor of Haemato-Oncology Centre for Sickle Cell Disease Research and Training (CESRTA) University of Abuja

Obiageli E. Nnodu Associate Professor of Haemato-Oncology Centre for Sickle Cell Disease Research and Training (CESRTA) University of Abuja Obiageli E. Nnodu Associate Professor of Haemato-Oncology Centre for Sickle Cell Disease Research and Training (CESRTA) University of Abuja Background Background of Cancer 2010 Three invitations and a

More information

Trends in HIV/AIDS epidemic in Asia, and its challenge. Taro Yamamoto Institute of Tropical Medicine Nagasaki University

Trends in HIV/AIDS epidemic in Asia, and its challenge. Taro Yamamoto Institute of Tropical Medicine Nagasaki University Trends in HIV/AIDS epidemic in Asia, and its challenge Taro Yamamoto Institute of Tropical Medicine Nagasaki University Millennium Development Goals Goal 1. Eradicate extreme poverty and hunger Goal 2.

More information

Pneumococcal vaccines

Pneumococcal vaccines Pneumococcal vaccines Marco Aurélio Sáfadi, MD, PhD FCM da Santa Casa de São Paulo Challenges in establishing the baseline burden of disease, before implementing a vaccination program S. pneumoniae disease

More information

Health Maintenance and Education for Children and Adults

Health Maintenance and Education for Children and Adults Health Maintenance and Education for Children and Adults Richard Ward, MSc, MRCP, FRCPath Director, Red Blood Cell Disorders Program, UHN Assistant Professor, Hematology, University of Toronto Chair, Canadian

More information

Flu season is near. Are you at risk?

Flu season is near. Are you at risk? Flu season is near Are you at risk? D New for 2007 Children under age 9 receiving an influenza vaccination for the first time need two doses approximately one month apart. Children between the ages of

More information

Indiana Immunization Task Force Progress Report

Indiana Immunization Task Force Progress Report Indiana Immunization Task Force Progress Report Report Published December 2009 Progress Report Published May 31, 2012 2344 Broadway Street, Indianapolis, IN 46205 Tel: 317-628-7116 Email: director@vaccinateindiana.org

More information

Monitoring of HIV positive mothers and HIV exposed infants in context of Option B+ implementation

Monitoring of HIV positive mothers and HIV exposed infants in context of Option B+ implementation Monitoring of HIV positive mothers and HIV exposed infants in context of Option B+ implementation Kenya Outline of the presentation Background: Kenya in Context PMTCT Program progress 2012-2015 Option

More information

Update on Status of Wild Poliovirus Outbreak in Kenya. 9 th Meeting of the IMB 1-3 October 2013 London, UK

Update on Status of Wild Poliovirus Outbreak in Kenya. 9 th Meeting of the IMB 1-3 October 2013 London, UK Update on Status of Wild Poliovirus Outbreak in Kenya 9 th Meeting of the IMB 1-3 October 2013 London, UK Contents Background Confirmation and Immediate Response High Risk Areas Coordination of Response

More information

IHN-CCO DST Final Report and Evaluation

IHN-CCO DST Final Report and Evaluation IHN-CCO DST Final Report and Evaluation Breastfeeding Support Services July 2016 to September 2018 Summary: This pilot reduced the barriers new mothers have in being able to successfully breastfeed their

More information

SCD Advocacy Talking Points!

SCD Advocacy Talking Points! "#$!%&'()*)+!,!-././-1!! SCD Advocacy Talking Points! * 23!4*'3!53*673&!84*8!#*59:(679*!#495&637;!9

More information

NCC Pediatrics Continuity Clinic Curriculum: Medical Home Module 2 Well Visits

NCC Pediatrics Continuity Clinic Curriculum: Medical Home Module 2 Well Visits NCC Pediatrics Continuity Clinic Curriculum: Medical Home Module 2 Well Visits Overall Goal: To identify strategies for providing comprehensive care during a well visit. The provision of comprehensive

More information

about VFR Parents and Children

about VFR Parents and Children Pre-CISTM Course, 24 May 2015 : Pediatric Travel Medicine: what we know, what we think we know and what we actually end up doing! about VFR Parents and Children Stefan Hagmann, MD MSc Associate Professor

More information

Guidelines for management of suspected sepsis in young infants where referral is not possible

Guidelines for management of suspected sepsis in young infants where referral is not possible Guidelines for management of suspected sepsis in young infants where referral is not possible Kenya Paediatrics Association Conference, 26-29 April 2016, Eldoret Kenya 1 Kenya Paediatrics Association Conference,

More information

Saving Young Lives IN AFRICA AND ASIA. A partnership to deliver care for acute kidney injury in the developing world

Saving Young Lives IN AFRICA AND ASIA. A partnership to deliver care for acute kidney injury in the developing world Saving Young Lives IN AFRICA AND ASIA A partnership to deliver care for acute kidney injury in the developing world The Compelling need for Saving Young Lives Children and young adults continue to die

More information

EVERY PARENT SHOULD ASK THEIR HEALTHCARE PROVIDER ABOUT VACCINATION

EVERY PARENT SHOULD ASK THEIR HEALTHCARE PROVIDER ABOUT VACCINATION 9 QUESTIONS 9 QUESTIONS EVERY PARENT SHOULD ASK THEIR PEDIATRICIAN ABOUT VACCINATION EVERY PARENT SHOULD ASK THEIR HEALTHCARE PROVIDER ABOUT VACCINATION Immunization is an important step that may help

More information

Integrated Community Case Management (iccm)

Integrated Community Case Management (iccm) Integrated Community Case Management (iccm) March, 2014 Issue Even though Ethiopia has achieved MDG 4 target, nearly 205,000 children are dying every year before they reach their fifth birthday. Every

More information

Risk profiles and vaccine uptake in children with invasive pneumococcal disease at a tertiary hospital in Tshwane:

Risk profiles and vaccine uptake in children with invasive pneumococcal disease at a tertiary hospital in Tshwane: Risk profiles and vaccine uptake in children with invasive pneumococcal disease at a tertiary hospital in Tshwane: A retrospective review Xandré Dearden www.up.ac.za IPD: disease spectrum and epidemiology

More information

The CIDRZ Experience: use of data to understand patient outcomes and guide program implementation 07 January 2010

The CIDRZ Experience: use of data to understand patient outcomes and guide program implementation 07 January 2010 The CIDRZ Experience: use of data to understand patient outcomes and guide program implementation 07 January 2010 Dr C Bolton Moore Deputy Medical Director CIDRZ Ministry of Health Zambia University of

More information

Global and National Trends in Vaccine Preventable Diseases. Dr Brenda Corcoran National Immunisation Office.

Global and National Trends in Vaccine Preventable Diseases. Dr Brenda Corcoran National Immunisation Office. Global and National Trends in Vaccine Preventable Diseases Dr Brenda Corcoran National Immunisation Office Global mortality 2008 Children under 5 years of age 1.5 million deaths due to vaccine preventable

More information

Preventing HIV morbidity & mortality: fast-tracking infants on to ART

Preventing HIV morbidity & mortality: fast-tracking infants on to ART Preventing HIV morbidity & mortality: fast-tracking infants on to ART Brian Eley Paediatric Infectious Diseases Unit Red Cross War Memorial Children s Hospital Department of Paediatrics & Child Health

More information

H1N1 PANDEMIC: LESSONS LEARNT VIEWS FROM A COUNTRY RECEIVING DONATED PRODUCTS

H1N1 PANDEMIC: LESSONS LEARNT VIEWS FROM A COUNTRY RECEIVING DONATED PRODUCTS H1N1 PANDEMIC: LESSONS LEARNT VIEWS FROM A COUNTRY RECEIVING DONATED PRODUCTS Delese Mimi Darko Head of Pharmacovigilance and Clinical Trials Food and Drugs Board, Ghana OUTLINE Ghana s Healthcare system

More information

Hepatitis B from targeted screening and immunisation of migrant mothers to universal immunisation in Australia

Hepatitis B from targeted screening and immunisation of migrant mothers to universal immunisation in Australia Hepatitis B from targeted screening and immunisation of migrant mothers to universal immunisation in Australia Tilman Ruff Nossal Institute for Global Health, University of Melbourne Consultant: Australian

More information

Every Opportunity in Partnership.. Child & Family Service working in Partnership to increase Human Papilloma Virus (HPV) coverage rates

Every Opportunity in Partnership.. Child & Family Service working in Partnership to increase Human Papilloma Virus (HPV) coverage rates Every Opportunity in Partnership.. Child & Family Service working in Partnership to increase Human Papilloma Virus (HPV) coverage rates Lorraine Glover [Immunisation Nurse Consultant] HUMAN PAPILLOMA VIRUS

More information

California 2010 Pertussis Epidemic. Kathleen Winter, MPH Immunization Branch California Department of Public Health

California 2010 Pertussis Epidemic. Kathleen Winter, MPH Immunization Branch California Department of Public Health California 2010 Pertussis Epidemic Kathleen Winter, MPH Immunization Branch California Department of Public Health Overview Pertussis Background California Pertussis Epidemic Challenges and Success Ongoing

More information

ELIMINATION OF VIRAL HEPATITIS IN ROMANIA LESSONS LEARNT AND THE WAY FORWARD

ELIMINATION OF VIRAL HEPATITIS IN ROMANIA LESSONS LEARNT AND THE WAY FORWARD ELIMINATION OF VIRAL HEPATITIS IN ROMANIA LESSONS LEARNT AND THE WAY FORWARD 17 May 2018 Bucharest, Romania Organisers Associations Collaborating on Hepatitis to Immunize and Eliminate the Viruses in Europe

More information

SUSTAINING ACCESS TO HIGH QUALITY RADIOTHERAPY CARE: A LMIC PERSPECTIVE

SUSTAINING ACCESS TO HIGH QUALITY RADIOTHERAPY CARE: A LMIC PERSPECTIVE SUSTAINING ACCESS TO HIGH QUALITY RADIOTHERAPY CARE: A LMIC PERSPECTIVE Dr Kennedy Lishimpi BSc MB ChB M.Med FC Rad Onc (SA) Director Cancer Control Ministry of Health Zambia ICARO2 21/06/17 Introduction

More information

Journal Club 3/4/2011

Journal Club 3/4/2011 Journal Club 3/4/2011 Maternal HIV Infection and Antibody Responses Against Vaccine-Preventable Diseases in Uninfected Infants JAMA. 2011 Feb 9;305(6):576-84. Jones et al Dept of Pediatrics, Imperial College,

More information

Newborn Screening and Followup for Hemoglobinopathies

Newborn Screening and Followup for Hemoglobinopathies Newborn Screening and Followup for Hemoglobinopathies October 4, 2012 Monica Hulbert, MD Director, Sickle Cell Disease Program Washington University School of Medicine St. Louis Children s Hospital Disclosures

More information

UNRELATED DONOR TRANSPLANTATION FOR SICKLE CELL DISEASE AN UPDATE

UNRELATED DONOR TRANSPLANTATION FOR SICKLE CELL DISEASE AN UPDATE UNRELATED DONOR TRANSPLANTATION FOR SICKLE CELL DISEASE AN UPDATE Naynesh Kamani, M.D. Children s National Medical Center GW University School of Medicine Washington, DC SCD scope of problem in USA Commonest

More information

Fig. 1 GPA s World PT Day Poster

Fig. 1 GPA s World PT Day Poster REPORT ON GHANA PHYSIOTHERAPY ASSOCIATION S CELEBRATION OF WORLD PHYSIOTHERAPY DAY, 2017 Physiotherapists the world over joined hearts and minds to commemorate the annual World Physical Therapy Day on

More information

Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014

Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014 Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014 Outline Background History of prevention of mother to child

More information

Fig. 64 Framework describing causes and consequences of maternal and child undernutriton

Fig. 64 Framework describing causes and consequences of maternal and child undernutriton 9.0 PREVALENCE OF MALNUTRITION 118 This chapter presents the prevalence of the three types of malnutrition (wasting, stunting and underweight) by background characteristic and livelihood zones in children

More information

AfroSickle: Network News To Promote Science and Improve Patient Care for SCD in Africa

AfroSickle: Network News To Promote Science and Improve Patient Care for SCD in Africa AfroSickle: Network News To Promote Science and Improve Patient Care for SCD in Africa Vol. 1 No. 4 Project Convener: Project Coordinators: R. Cooper Nallely Mora rcooper@lumc.edu namora@lumc.edu Helen

More information

HEPATITIS ELIMINATION IN SUB-SAHARAN AFRICA: WHAT WILL IT TAKE?

HEPATITIS ELIMINATION IN SUB-SAHARAN AFRICA: WHAT WILL IT TAKE? HEPATITIS ELIMINATION IN SUB-SAHARAN AFRICA: WHAT WILL IT TAKE? Ganiyat Kikelomo OYELEKE FMCP Hepatologist & Gastroenterologist Lagos University Teaching Hospital, Nigeria. INTEREST 2018, KIGALI CONFERENCE

More information

Designing trials for uncommon diseases and therapeutics. Mark Walters

Designing trials for uncommon diseases and therapeutics. Mark Walters Designing trials for uncommon diseases and therapeutics Mark Walters What are Hemoglobin? Alterations in the hemoglobin molecule that adversely affect its abundance and/or function and stability Account

More information

California Department of Public Health California Department of Public Health California Department of Public Health

California Department of Public Health California Department of Public Health California Department of Public Health 2012 CIC Education Hour: January 24, 2012 Navigating Adolescent Vaccinations through Private and Safety Net Providers Contact Information Claudia Aguiluz, VFC Program Coordinator Claudia.aguiluz@cdph.ca.gov

More information

Prince Albert Parkland Regional Health Authority Immunization coverage

Prince Albert Parkland Regional Health Authority Immunization coverage Prince Albert Parkland Regional Health Authority Immunization coverage Introduction...91 Background...91 Our audit objective, conclusion, and recommendations...92 Our findings by criteria...93 Promote

More information

HIV POSITIVE YOUTH: LINKAGE & RETENTION IN CARE

HIV POSITIVE YOUTH: LINKAGE & RETENTION IN CARE HIV POSITIVE YOUTH: LINKAGE & RETENTION IN CARE Site C Youth clinic HIV care pathway DAY 1 Test HIV + PIMA point of care CD4 count in in 3-5 days initiation + in session 3 session 4 1 month Youth Club

More information

History, implementation and impact of MenA conjugate on disease burden in Africa

History, implementation and impact of MenA conjugate on disease burden in Africa History, implementation and impact of MenA conjugate on disease burden in Africa First Regional Meningococcal Symposium, 19-20 March 2012 Buenos Aires, Argentina Co-hosted by the Sabin Vaccine Institute

More information

KENYA LAUNCHES TEN VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV 10)

KENYA LAUNCHES TEN VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV 10) KENYA LAUNCHES TEN VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV 10) Nairobi, 14 th February 2011 - Hundreds of infants in Kenya received their first shots against pneumococcal disease today at a special

More information

Status of RTS,S/AS01 malaria vaccine candidate

Status of RTS,S/AS01 malaria vaccine candidate Status of RTS,S/AS01 malaria vaccine candidate Multi-center RTS,S malaria vaccine efficacy trial Phase 3, randomized, controlled, double-blind trial conducted in 11 centers in 7 African countries 15,460

More information

Maternal, Child and Reproductive Health Initiative

Maternal, Child and Reproductive Health Initiative Maternal, Child and Reproductive Health Initiative Maternal, Child and Reproductive Health Initiative The Maternal, Child and Reproductive Health (MCRH) Initiative works in developing countries to improve

More information

SICKLE CELL AWARENESS. The Sickle Cell Society has produced the following information leaflets available at sicklecellsociety.org

SICKLE CELL AWARENESS. The Sickle Cell Society has produced the following information leaflets available at sicklecellsociety.org sickle cell disease in the UK Sickle cell disease (SCD) affects around 15,000 people in the UK People with Sickle Cell Disease have Sickle haemoglobin (HbS) which can make red blood cells rigid and sickle-shaped

More information

The State of Measles and Rubella in the WHO European Region

The State of Measles and Rubella in the WHO European Region The State of Measles and Rubella in the WHO European Region Mark Muscat Vaccine-preventable Diseases and Immunization Rome, Italy, 16-17 June 2016 All six WHO Regions have measles elimination goals 2 Annual

More information

UHC. Moving toward. Ghana NATIONAL INITIATIVES, KEY CHALLENGES, AND THE ROLE OF COLLABORATIVE ACTIVITIES. Public Disclosure Authorized

UHC. Moving toward. Ghana NATIONAL INITIATIVES, KEY CHALLENGES, AND THE ROLE OF COLLABORATIVE ACTIVITIES. Public Disclosure Authorized Public Disclosure Authorized Public Disclosure Authorized Moving toward UHC Ghana NATIONAL INITIATIVES, KEY CHALLENGES, AND THE ROLE OF COLLABORATIVE ACTIVITIES re Authorized Public Disclosure Authorized

More information

HBV in New Zealand Community HBV screening to long-term follow-up

HBV in New Zealand Community HBV screening to long-term follow-up HBsAg+ icteric hepatitis (n) % anti-hbcore+ 26/9/214 HBV in New Zealand Community HBV screening to long-term follow-up John Hornell, CEO, A registered charitable trust whose mission is: To improve health

More information

TRANSLATING RESEARCH INTO POLICY AND PRACTICE - Examples from HDSS Centres

TRANSLATING RESEARCH INTO POLICY AND PRACTICE - Examples from HDSS Centres TRANSLATING RESEARCH INTO POLICY AND PRACTICE - Examples from HDSS Centres Four HDSS centres were selected to provide examples of their work in translating research into policies or practice. As stated

More information

INTRODUCTION. 204 MCHIP End-of-Project Report

INTRODUCTION. 204 MCHIP End-of-Project Report Redacted INTRODUCTION Three randomized clinical trials determined unequivocally that male circumcision (MC) reduces female-to-male HIV transmission by approximately 60%. 1,2,3 Modeling studies demonstrate

More information

Pneumococcal polysaccharide vaccine uptake in England, , prior to the introduction of a vaccination programme for older adults

Pneumococcal polysaccharide vaccine uptake in England, , prior to the introduction of a vaccination programme for older adults Journal of Public Health Advance Access published July 7, 2006 Journal of Public Health pp. 1 of 6 doi:10.1093/pubmed/fdl017 Pneumococcal polysaccharide vaccine uptake in England, 1989 2003, prior to the

More information